Ardelyx Inc (NASDAQ: ARDX) kicked off on November 20, 2023, at the price of $4.34, up 1.15% from the previous trading day. During the day, the shares moved up to $4.435 and dropped to $4.28 before settling in for the closing price of $4.33. Over the past 52 weeks, ARDX has traded in a range of $1.64-$5.12.
Annual sales at Healthcare sector company grew by 100.41% over the past five years. While this was happening, its average annual earnings per share was recorded 28.73%. With a float of $222.68 million, this company’s outstanding shares have now reached $232.14 million.
Let’s look at the performance matrix of the company that is accounted for 133 employees. In terms of profitability, gross margin is +83.29, operating margin of -122.24, and the pretax margin is -128.84.
Ardelyx Inc (ARDX) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Ardelyx Inc is 4.08%, while institutional ownership is 54.26%. The most recent insider transaction that took place on Nov 15, was worth 99,998. In this transaction Chief Medical Officer of this company sold 25,000 shares at a rate of $4.00, taking the stock ownership to the 266,839 shares. Before that another transaction happened on Oct 10, when Company’s Chief Development Officer sold 1,644 for $4.00, making the entire transaction worth $6,576. This insider now owns 365,378 shares in total.
Ardelyx Inc (ARDX) Performance Highlights and Predictions
In the latest quarterly report, which was put into the public domain on 9/29/2023, the organization reported $0.03 earnings per share (EPS), higher than consensus estimate (set at -$0.11) by $0.14. This company achieved a net margin of -128.85 while generating a return on equity of -74.28. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.11 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 28.73% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 30.00% during the next five years compared to 20.81% growth over the previous five years of trading.
Ardelyx Inc (NASDAQ: ARDX) Trading Performance Indicators
Take a look at Ardelyx Inc’s (ARDX) current performance indicators. Last quarter, stock had a quick ratio of 5.35. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.57.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.12, a number that is poised to hit -0.10 in the next quarter and is forecasted to reach -0.24 in one year’s time.
Technical Analysis of Ardelyx Inc (ARDX)
Ardelyx Inc (NASDAQ: ARDX) saw its 5-day average volume 5.01 million, a negative change from its year-to-date volume of 6.27 million. As of the previous 9 days, the stock’s Stochastic %D was 88.63%. Additionally, its Average True Range was 0.26.
During the past 100 days, Ardelyx Inc’s (ARDX) raw stochastic average was set at 67.40%, which indicates a significant decrease from 93.14% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 64.08% in the past 14 days, which was lower than the 71.24% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.91, while its 200-day Moving Average is $3.89. Nevertheless, the first resistance level for the watch stands at $4.45 in the near term. At $4.52, the stock is likely to face the second major resistance level. The third major resistance level sits at $4.60. If the price goes on to break the first support level at $4.30, it is likely to go to the next support level at $4.21. Assuming the price breaks the second support level, the third support level stands at $4.14.
Ardelyx Inc (NASDAQ: ARDX) Key Stats
The company with the Market Capitalisation of 1.02 billion has total of 232,100K Shares Outstanding. Its annual sales at the moment are 52,160 K in contrast with the sum of -67,210 K annual income. Company’s last quarter sales were recorded 56,390 K and last quarter income was 6,630 K.